Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2023-08-28 Governance Information
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
Appendix 4G 14 pages 342.2KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' for 4DMedical Limited for the financial year ended 30 June 2023. It references ASX Listing Rules 4.7.3 and 4.10.3, which require listed entities to lodge an Appendix 4G alongside their annual report to confirm compliance with corporate governance disclosure requirements. The document is a detailed checklist indicating which governance recommendations have been followed or not, with references to where disclosures can be found (e.g., corporate governance statement on the website or annual report pages). It explicitly states that Appendix 4G is not a substitute for the corporate governance statement but serves as a verification tool. The content is focused on governance disclosures and compliance with ASX corporate governance principles, not on financial results, management changes, or other report types. This matches the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length (15,000 characters) and detailed content confirm it is the actual governance disclosure document, not a brief announcement or certification. Therefore, the correct classification is CGR with high confidence.
2023-08-28 English
Notice of AGM Date 1 page 147.9KB
AGM Information Classification · 95% confidence The document is an ASX announcement regarding the date of the company's next Annual General Meeting (AGM) scheduled for 2 November 2023. It mentions the election of directors at the AGM and the closing date for director nominations. The document does not contain any financial data, detailed reports, or presentations but is an announcement about the AGM date and related procedural information. The document length is short (2354 characters), and it fits the description of an AGM Information announcement rather than the actual AGM materials or reports. Therefore, the appropriate classification is AGM Information (AGM-R).
2023-08-28 English
Notification regarding unquoted securities - 4DX 9 pages 33.9KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted securities such as performance rights and options under an employee incentive scheme. It includes specifics about the number of securities issued, issue dates, and references to the company's Long Term Incentive Plan. There is no indication of financial statements, management discussion, or earnings data. The content is focused on the issuance of securities, which aligns with announcements about share issues or capital changes. The document length is 8303 characters, which is substantive and contains detailed issuance information, not just a brief announcement or link to a report. Therefore, the document fits the category of Share Issue/Capital Change (SHA).
2023-08-14 English
Notification of cessation of securities - 4DX 6 pages 27.7KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the lapse of conditional rights to securities (options) for 4DMEDICAL LIMITED. It provides specific information about securities that have ceased, including ASX security codes, descriptions, numbers, and reasons for cessation. The document is a formal announcement about changes in the company's issued capital related to securities that have lapsed or ceased. It does not contain financial statements, management discussion, or detailed financial results. It is not an annual or interim report, nor an earnings release or audit report. It is also not a regulatory certification or a proxy solicitation. The content fits best with announcements related to changes in capital structure or securities status. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (6080 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2023-08-07 English
Statement pursuant to Listing Rule 4.7C.3 1 page 14
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 2 August 2023, referencing Listing Rule 4.7C.3. It reports payments to related parties (executive and non-executive directors) during the quarter ended 30 June 2023, specifically $350k for salaries and fees. The content is a regulatory disclosure about related party payments for a quarterly period, consistent with a regulatory filing rather than a full financial report or detailed management discussion. The document length is short (2234 characters) and it does not contain financial statements or detailed analysis, only a brief statement of related party payments. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance announcements that do not fit other specific categories.
2023-08-01 English
Quarterly Activity Report and Appendix 4C for Q4 FY2023 11 pages 805.1KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activity Report and Appendix 4C for Q4 FY2023' and dated 31 July 2023. It contains detailed financial performance data for the quarter and fiscal year to date, including cash receipts, operating cash outflows, and cash balances. It also discusses a successful capital raise of $45 million, commercial milestones, product development updates, and management role changes. The presence of substantive financial data and analysis for a quarter (Q4 FY2023) indicates this is a comprehensive interim/quarterly report rather than a brief announcement or presentation. The document length (15,000 characters) and detailed financial and operational content confirm it is not a short announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q4 2023
2023-07-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.